HomeAQSZF • OTCMKTS
add
Aequus Pharmaceuticals Inc
Previous close
$0.0020
Year range
$0.00010 - $0.0078
Market cap
663.17K CAD
Avg Volume
5.89K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 251.75K | 69.74% |
Operating expense | 219.75K | -64.75% |
Net income | 370.48K | 160.27% |
Net profit margin | 147.16 | 135.51% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.86K | -45.45% |
Total assets | 196.16K | -77.14% |
Total liabilities | 7.09M | 0.16% |
Total equity | -6.89M | — |
Shares outstanding | 132.63M | — |
Price to book | -0.04 | — |
Return on assets | -101.44% | — |
Return on capital | 29.23% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 370.48K | 160.27% |
Cash from operations | -21.22K | 93.91% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -21.22K | -13.64% |
Free cash flow | 124.83K | 153.72% |
About
Founded
2013
Headquarters
Website
Employees
12
